Epigenomics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=903491, encodeId=9d21903491b8, content=求问一下，在web of science 上没查到近几年的文章和JCR分区，是怎么回事呢？这个现在是JCR几区呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22615439861, createdName=ms1000002096547591, createdTime=Mon Nov 30 10:14:12 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892795, encodeId=c620892e959a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问在系统投稿后，没有要求每位作者必须邮件回复ORCID ID吧？投了几天了一直Under Consideration,感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Sun Oct 18 10:46:41 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892994, encodeId=67fa892994f0, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:51 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892993, encodeId=47758929930b, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:46 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803117, encodeId=9f2b80311ee8, content=审稿速度:2.0 经验分享：已经修回去一周了，没反应，不急，不急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/13/5f6e37d73abba73972b434fe17f53633.jpg, createdBy=4c541979623, createdName=1e17d575m20(暂无匿称), createdTime=Fri Jul 17 16:23:08 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893442, encodeId=c0e8893442ed, content=请问投稿Epigenomic 后，有必要每个作者邮件回复邮件ORCID ID 吗，好像投稿须知里没写必须啊，但我投了一周了一直是under consideration，，，在想要不要每位作者都回复下呢，谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Wed Oct 21 06:27:50 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808213, encodeId=cd1b80821378, content=必须是表观相关吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed Aug 12 16:10:49 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591316, encodeId=74055913169d, content=我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？158****1683暂无昵称 2020-05-20 00:00:00 发表: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, beContent=158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591288, encodeId=a872591288ef, content=谢谢！请问期间状态一直是in consideration？渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右渴望蓝天的毛毛虫 2020-05-20 00:00:00 发表: 一般两周左右, beContent=渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591271, encodeId=10575912e12b, content=一般两周左右158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, beContent=158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201029/0ad40a3509894ae5912134803fe87ecb/23571cb0d75f4d3dac20f13facb011ff.jpg, createdBy=16065103091, createdName=渴望蓝天的毛毛虫, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-11-30 ms1000002096547591

求问一下，在web of science 上没查到近几年的文章和JCR分区，是怎么回事呢？这个现在是JCR几区呀？

98 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=903491, encodeId=9d21903491b8, content=求问一下，在web of science 上没查到近几年的文章和JCR分区，是怎么回事呢？这个现在是JCR几区呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22615439861, createdName=ms1000002096547591, createdTime=Mon Nov 30 10:14:12 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892795, encodeId=c620892e959a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问在系统投稿后，没有要求每位作者必须邮件回复ORCID ID吧？投了几天了一直Under Consideration,感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Sun Oct 18 10:46:41 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892994, encodeId=67fa892994f0, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:51 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892993, encodeId=47758929930b, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:46 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803117, encodeId=9f2b80311ee8, content=审稿速度:2.0 经验分享：已经修回去一周了，没反应，不急，不急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/13/5f6e37d73abba73972b434fe17f53633.jpg, createdBy=4c541979623, createdName=1e17d575m20(暂无匿称), createdTime=Fri Jul 17 16:23:08 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893442, encodeId=c0e8893442ed, content=请问投稿Epigenomic 后，有必要每个作者邮件回复邮件ORCID ID 吗，好像投稿须知里没写必须啊，但我投了一周了一直是under consideration，，，在想要不要每位作者都回复下呢，谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Wed Oct 21 06:27:50 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808213, encodeId=cd1b80821378, content=必须是表观相关吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed Aug 12 16:10:49 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591316, encodeId=74055913169d, content=我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？158****1683暂无昵称 2020-05-20 00:00:00 发表: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, beContent=158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591288, encodeId=a872591288ef, content=谢谢！请问期间状态一直是in consideration？渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右渴望蓝天的毛毛虫 2020-05-20 00:00:00 发表: 一般两周左右, beContent=渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591271, encodeId=10575912e12b, content=一般两周左右158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, beContent=158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201029/0ad40a3509894ae5912134803fe87ecb/23571cb0d75f4d3dac20f13facb011ff.jpg, createdBy=16065103091, createdName=渴望蓝天的毛毛虫, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-10-18 Andydld

审稿速度:2.0 | 投稿命中率:50.0
经验分享：请问在系统投稿后，没有要求每位作者必须邮件回复ORCID ID吧？投了几天了一直Under Consideration,感谢感谢！

110 0

[GetPortalCommentsPageByObjectIdResponse(id=903491, encodeId=9d21903491b8, content=求问一下，在web of science 上没查到近几年的文章和JCR分区，是怎么回事呢？这个现在是JCR几区呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22615439861, createdName=ms1000002096547591, createdTime=Mon Nov 30 10:14:12 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892795, encodeId=c620892e959a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问在系统投稿后，没有要求每位作者必须邮件回复ORCID ID吧？投了几天了一直Under Consideration,感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Sun Oct 18 10:46:41 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892994, encodeId=67fa892994f0, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:51 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892993, encodeId=47758929930b, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:46 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803117, encodeId=9f2b80311ee8, content=审稿速度:2.0 经验分享：已经修回去一周了，没反应，不急，不急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/13/5f6e37d73abba73972b434fe17f53633.jpg, createdBy=4c541979623, createdName=1e17d575m20(暂无匿称), createdTime=Fri Jul 17 16:23:08 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893442, encodeId=c0e8893442ed, content=请问投稿Epigenomic 后，有必要每个作者邮件回复邮件ORCID ID 吗，好像投稿须知里没写必须啊，但我投了一周了一直是under consideration，，，在想要不要每位作者都回复下呢，谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Wed Oct 21 06:27:50 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808213, encodeId=cd1b80821378, content=必须是表观相关吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed Aug 12 16:10:49 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591316, encodeId=74055913169d, content=我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？158****1683暂无昵称 2020-05-20 00:00:00 发表: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, beContent=158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591288, encodeId=a872591288ef, content=谢谢！请问期间状态一直是in consideration？渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右渴望蓝天的毛毛虫 2020-05-20 00:00:00 发表: 一般两周左右, beContent=渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591271, encodeId=10575912e12b, content=一般两周左右158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, beContent=158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201029/0ad40a3509894ae5912134803fe87ecb/23571cb0d75f4d3dac20f13facb011ff.jpg, createdBy=16065103091, createdName=渴望蓝天的毛毛虫, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-10-19 Andydld

请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！

97 0

[GetPortalCommentsPageByObjectIdResponse(id=903491, encodeId=9d21903491b8, content=求问一下，在web of science 上没查到近几年的文章和JCR分区，是怎么回事呢？这个现在是JCR几区呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22615439861, createdName=ms1000002096547591, createdTime=Mon Nov 30 10:14:12 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892795, encodeId=c620892e959a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问在系统投稿后，没有要求每位作者必须邮件回复ORCID ID吧？投了几天了一直Under Consideration,感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Sun Oct 18 10:46:41 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892994, encodeId=67fa892994f0, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:51 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892993, encodeId=47758929930b, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:46 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803117, encodeId=9f2b80311ee8, content=审稿速度:2.0 经验分享：已经修回去一周了，没反应，不急，不急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/13/5f6e37d73abba73972b434fe17f53633.jpg, createdBy=4c541979623, createdName=1e17d575m20(暂无匿称), createdTime=Fri Jul 17 16:23:08 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893442, encodeId=c0e8893442ed, content=请问投稿Epigenomic 后，有必要每个作者邮件回复邮件ORCID ID 吗，好像投稿须知里没写必须啊，但我投了一周了一直是under consideration，，，在想要不要每位作者都回复下呢，谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Wed Oct 21 06:27:50 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808213, encodeId=cd1b80821378, content=必须是表观相关吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed Aug 12 16:10:49 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591316, encodeId=74055913169d, content=我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？158****1683暂无昵称 2020-05-20 00:00:00 发表: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, beContent=158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591288, encodeId=a872591288ef, content=谢谢！请问期间状态一直是in consideration？渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右渴望蓝天的毛毛虫 2020-05-20 00:00:00 发表: 一般两周左右, beContent=渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591271, encodeId=10575912e12b, content=一般两周左右158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, beContent=158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201029/0ad40a3509894ae5912134803fe87ecb/23571cb0d75f4d3dac20f13facb011ff.jpg, createdBy=16065103091, createdName=渴望蓝天的毛毛虫, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-10-19 Andydld

请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！

98 0

[GetPortalCommentsPageByObjectIdResponse(id=903491, encodeId=9d21903491b8, content=求问一下，在web of science 上没查到近几年的文章和JCR分区，是怎么回事呢？这个现在是JCR几区呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22615439861, createdName=ms1000002096547591, createdTime=Mon Nov 30 10:14:12 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892795, encodeId=c620892e959a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问在系统投稿后，没有要求每位作者必须邮件回复ORCID ID吧？投了几天了一直Under Consideration,感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Sun Oct 18 10:46:41 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892994, encodeId=67fa892994f0, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:51 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892993, encodeId=47758929930b, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:46 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803117, encodeId=9f2b80311ee8, content=审稿速度:2.0 经验分享：已经修回去一周了，没反应，不急，不急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/13/5f6e37d73abba73972b434fe17f53633.jpg, createdBy=4c541979623, createdName=1e17d575m20(暂无匿称), createdTime=Fri Jul 17 16:23:08 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893442, encodeId=c0e8893442ed, content=请问投稿Epigenomic 后，有必要每个作者邮件回复邮件ORCID ID 吗，好像投稿须知里没写必须啊，但我投了一周了一直是under consideration，，，在想要不要每位作者都回复下呢，谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Wed Oct 21 06:27:50 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808213, encodeId=cd1b80821378, content=必须是表观相关吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed Aug 12 16:10:49 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591316, encodeId=74055913169d, content=我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？158****1683暂无昵称 2020-05-20 00:00:00 发表: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, beContent=158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591288, encodeId=a872591288ef, content=谢谢！请问期间状态一直是in consideration？渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右渴望蓝天的毛毛虫 2020-05-20 00:00:00 发表: 一般两周左右, beContent=渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591271, encodeId=10575912e12b, content=一般两周左右158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, beContent=158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201029/0ad40a3509894ae5912134803fe87ecb/23571cb0d75f4d3dac20f13facb011ff.jpg, createdBy=16065103091, createdName=渴望蓝天的毛毛虫, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-07-17 1e17d575m20(暂无匿称)

审稿速度:2.0
经验分享：已经修回去一周了，没反应，不急，不急

124 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=903491, encodeId=9d21903491b8, content=求问一下，在web of science 上没查到近几年的文章和JCR分区，是怎么回事呢？这个现在是JCR几区呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22615439861, createdName=ms1000002096547591, createdTime=Mon Nov 30 10:14:12 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892795, encodeId=c620892e959a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问在系统投稿后，没有要求每位作者必须邮件回复ORCID ID吧？投了几天了一直Under Consideration,感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Sun Oct 18 10:46:41 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892994, encodeId=67fa892994f0, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:51 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892993, encodeId=47758929930b, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:46 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803117, encodeId=9f2b80311ee8, content=审稿速度:2.0 经验分享：已经修回去一周了，没反应，不急，不急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/13/5f6e37d73abba73972b434fe17f53633.jpg, createdBy=4c541979623, createdName=1e17d575m20(暂无匿称), createdTime=Fri Jul 17 16:23:08 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893442, encodeId=c0e8893442ed, content=请问投稿Epigenomic 后，有必要每个作者邮件回复邮件ORCID ID 吗，好像投稿须知里没写必须啊，但我投了一周了一直是under consideration，，，在想要不要每位作者都回复下呢，谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Wed Oct 21 06:27:50 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808213, encodeId=cd1b80821378, content=必须是表观相关吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed Aug 12 16:10:49 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591316, encodeId=74055913169d, content=我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？158****1683暂无昵称 2020-05-20 00:00:00 发表: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, beContent=158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591288, encodeId=a872591288ef, content=谢谢！请问期间状态一直是in consideration？渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右渴望蓝天的毛毛虫 2020-05-20 00:00:00 发表: 一般两周左右, beContent=渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591271, encodeId=10575912e12b, content=一般两周左右158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, beContent=158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201029/0ad40a3509894ae5912134803fe87ecb/23571cb0d75f4d3dac20f13facb011ff.jpg, createdBy=16065103091, createdName=渴望蓝天的毛毛虫, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-10-21 Andydld

请问投稿Epigenomic 后，有必要每个作者邮件回复邮件ORCID ID 吗，好像投稿须知里没写必须啊，但我投了一周了一直是under consideration，，，在想要不要每位作者都回复下呢，谢谢~

104 0

[GetPortalCommentsPageByObjectIdResponse(id=903491, encodeId=9d21903491b8, content=求问一下，在web of science 上没查到近几年的文章和JCR分区，是怎么回事呢？这个现在是JCR几区呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22615439861, createdName=ms1000002096547591, createdTime=Mon Nov 30 10:14:12 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892795, encodeId=c620892e959a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问在系统投稿后，没有要求每位作者必须邮件回复ORCID ID吧？投了几天了一直Under Consideration,感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Sun Oct 18 10:46:41 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892994, encodeId=67fa892994f0, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:51 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892993, encodeId=47758929930b, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:46 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803117, encodeId=9f2b80311ee8, content=审稿速度:2.0 经验分享：已经修回去一周了，没反应，不急，不急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/13/5f6e37d73abba73972b434fe17f53633.jpg, createdBy=4c541979623, createdName=1e17d575m20(暂无匿称), createdTime=Fri Jul 17 16:23:08 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893442, encodeId=c0e8893442ed, content=请问投稿Epigenomic 后，有必要每个作者邮件回复邮件ORCID ID 吗，好像投稿须知里没写必须啊，但我投了一周了一直是under consideration，，，在想要不要每位作者都回复下呢，谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Wed Oct 21 06:27:50 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808213, encodeId=cd1b80821378, content=必须是表观相关吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed Aug 12 16:10:49 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591316, encodeId=74055913169d, content=我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？158****1683暂无昵称 2020-05-20 00:00:00 发表: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, beContent=158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591288, encodeId=a872591288ef, content=谢谢！请问期间状态一直是in consideration？渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右渴望蓝天的毛毛虫 2020-05-20 00:00:00 发表: 一般两周左右, beContent=渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591271, encodeId=10575912e12b, content=一般两周左右158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, beContent=158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201029/0ad40a3509894ae5912134803fe87ecb/23571cb0d75f4d3dac20f13facb011ff.jpg, createdBy=16065103091, createdName=渴望蓝天的毛毛虫, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-08-12 145d9400m83暂无昵称

必须是表观相关吗

98 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=903491, encodeId=9d21903491b8, content=求问一下，在web of science 上没查到近几年的文章和JCR分区，是怎么回事呢？这个现在是JCR几区呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22615439861, createdName=ms1000002096547591, createdTime=Mon Nov 30 10:14:12 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892795, encodeId=c620892e959a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问在系统投稿后，没有要求每位作者必须邮件回复ORCID ID吧？投了几天了一直Under Consideration,感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Sun Oct 18 10:46:41 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892994, encodeId=67fa892994f0, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:51 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892993, encodeId=47758929930b, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:46 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803117, encodeId=9f2b80311ee8, content=审稿速度:2.0 经验分享：已经修回去一周了，没反应，不急，不急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/13/5f6e37d73abba73972b434fe17f53633.jpg, createdBy=4c541979623, createdName=1e17d575m20(暂无匿称), createdTime=Fri Jul 17 16:23:08 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893442, encodeId=c0e8893442ed, content=请问投稿Epigenomic 后，有必要每个作者邮件回复邮件ORCID ID 吗，好像投稿须知里没写必须啊，但我投了一周了一直是under consideration，，，在想要不要每位作者都回复下呢，谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Wed Oct 21 06:27:50 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808213, encodeId=cd1b80821378, content=必须是表观相关吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed Aug 12 16:10:49 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591316, encodeId=74055913169d, content=我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？158****1683暂无昵称 2020-05-20 00:00:00 发表: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, beContent=158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591288, encodeId=a872591288ef, content=谢谢！请问期间状态一直是in consideration？渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右渴望蓝天的毛毛虫 2020-05-20 00:00:00 发表: 一般两周左右, beContent=渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591271, encodeId=10575912e12b, content=一般两周左右158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, beContent=158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201029/0ad40a3509894ae5912134803fe87ecb/23571cb0d75f4d3dac20f13facb011ff.jpg, createdBy=16065103091, createdName=渴望蓝天的毛毛虫, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-05-20 With_yan

我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样158****1683暂无昵称 2020-05-20 发表::
是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？158****1683暂无昵称 2020-05-20 00:00:00 发表:
是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？

158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？

86 0

[GetPortalCommentsPageByObjectIdResponse(id=903491, encodeId=9d21903491b8, content=求问一下，在web of science 上没查到近几年的文章和JCR分区，是怎么回事呢？这个现在是JCR几区呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22615439861, createdName=ms1000002096547591, createdTime=Mon Nov 30 10:14:12 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892795, encodeId=c620892e959a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问在系统投稿后，没有要求每位作者必须邮件回复ORCID ID吧？投了几天了一直Under Consideration,感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Sun Oct 18 10:46:41 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892994, encodeId=67fa892994f0, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:51 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892993, encodeId=47758929930b, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:46 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803117, encodeId=9f2b80311ee8, content=审稿速度:2.0 经验分享：已经修回去一周了，没反应，不急，不急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/13/5f6e37d73abba73972b434fe17f53633.jpg, createdBy=4c541979623, createdName=1e17d575m20(暂无匿称), createdTime=Fri Jul 17 16:23:08 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893442, encodeId=c0e8893442ed, content=请问投稿Epigenomic 后，有必要每个作者邮件回复邮件ORCID ID 吗，好像投稿须知里没写必须啊，但我投了一周了一直是under consideration，，，在想要不要每位作者都回复下呢，谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Wed Oct 21 06:27:50 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808213, encodeId=cd1b80821378, content=必须是表观相关吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed Aug 12 16:10:49 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591316, encodeId=74055913169d, content=我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？158****1683暂无昵称 2020-05-20 00:00:00 发表: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, beContent=158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591288, encodeId=a872591288ef, content=谢谢！请问期间状态一直是in consideration？渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右渴望蓝天的毛毛虫 2020-05-20 00:00:00 发表: 一般两周左右, beContent=渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591271, encodeId=10575912e12b, content=一般两周左右158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, beContent=158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201029/0ad40a3509894ae5912134803fe87ecb/23571cb0d75f4d3dac20f13facb011ff.jpg, createdBy=16065103091, createdName=渴望蓝天的毛毛虫, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-05-20 145d9400m83暂无昵称

谢谢！请问期间状态一直是in consideration？渴望蓝天的毛毛虫 2020-05-20 发表::
一般两周左右渴望蓝天的毛毛虫 2020-05-20 00:00:00 发表:
一般两周左右

渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右

106 0

[GetPortalCommentsPageByObjectIdResponse(id=903491, encodeId=9d21903491b8, content=求问一下，在web of science 上没查到近几年的文章和JCR分区，是怎么回事呢？这个现在是JCR几区呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22615439861, createdName=ms1000002096547591, createdTime=Mon Nov 30 10:14:12 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892795, encodeId=c620892e959a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问在系统投稿后，没有要求每位作者必须邮件回复ORCID ID吧？投了几天了一直Under Consideration,感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Sun Oct 18 10:46:41 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892994, encodeId=67fa892994f0, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:51 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892993, encodeId=47758929930b, content=请问大家，投稿Epigenomic 后，有必要每个作者回复邮件ORCID ID 吗，好像投稿须知里，没写必须啊，一直是under consideration，请过来人指点，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Mon Oct 19 10:27:46 CST 2020, time=2020-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803117, encodeId=9f2b80311ee8, content=审稿速度:2.0 经验分享：已经修回去一周了，没反应，不急，不急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/13/5f6e37d73abba73972b434fe17f53633.jpg, createdBy=4c541979623, createdName=1e17d575m20(暂无匿称), createdTime=Fri Jul 17 16:23:08 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893442, encodeId=c0e8893442ed, content=请问投稿Epigenomic 后，有必要每个作者邮件回复邮件ORCID ID 吗，好像投稿须知里没写必须啊，但我投了一周了一直是under consideration，，，在想要不要每位作者都回复下呢，谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/RKNSic0k9zAY0iawg9hlb7EJJRgsjnlE4eaiaE0JZbWZrIhQMyUjl8LXbStBFcjAexIUN9lOLIVCia4icDSjUvlGjLQ/132, createdBy=52731973446, createdName=Andydld, createdTime=Wed Oct 21 06:27:50 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808213, encodeId=cd1b80821378, content=必须是表观相关吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed Aug 12 16:10:49 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591316, encodeId=74055913169d, content=我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？158****1683暂无昵称 2020-05-20 00:00:00 发表: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, beContent=158****1683暂无昵称 2020-05-20 发表:: 是的，请问你的现在审几天了？是一直under review 还是由under consideration变成under review 的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591288, encodeId=a872591288ef, content=谢谢！请问期间状态一直是in consideration？渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右渴望蓝天的毛毛虫 2020-05-20 00:00:00 发表: 一般两周左右, beContent=渴望蓝天的毛毛虫 2020-05-20 发表:: 一般两周左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591271, encodeId=10575912e12b, content=一般两周左右158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, beContent=158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201029/0ad40a3509894ae5912134803fe87ecb/23571cb0d75f4d3dac20f13facb011ff.jpg, createdBy=16065103091, createdName=渴望蓝天的毛毛虫, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-05-20 渴望蓝天的毛毛虫

一般两周左右158****1683暂无昵称 2020-05-19 00:00:00 发表:
请问现在加速一审一般多久？

158****1683暂无昵称 2020-05-19 00:00:00 发表: 请问现在加速一审一般多久？

99 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务